3 Leading Dividend Stocks To Consider With Up To 5.6% Yield

Simply Wall St.
02-27

As U.S. markets experience a slight rebound with the S&P 500 and Nasdaq Composite snapping a four-day losing streak, investors continue to navigate economic uncertainties and policy impacts from the current administration. In this environment, dividend stocks can offer stability and potential income, making them an attractive option for those looking to balance growth with regular returns.

Top 10 Dividend Stocks In The United States

Name Dividend Yield Dividend Rating
Columbia Banking System (NasdaqGS:COLB) 5.43% ★★★★★★
Interpublic Group of Companies (NYSE:IPG) 4.77% ★★★★★★
FMC (NYSE:FMC) 6.07% ★★★★★★
Peoples Bancorp (NasdaqGS:PEBO) 5.07% ★★★★★★
Southside Bancshares (NYSE:SBSI) 4.76% ★★★★★★
Isabella Bank (OTCPK:ISBA) 4.55% ★★★★★★
Dillard's (NYSE:DDS) 5.96% ★★★★★★
Citizens & Northern (NasdaqCM:CZNC) 5.32% ★★★★★★
Virtus Investment Partners (NYSE:VRTS) 4.97% ★★★★★★
First Interstate BancSystem (NasdaqGS:FIBK) 6.20% ★★★★★★

Click here to see the full list of 143 stocks from our Top US Dividend Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Artesian Resources

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Artesian Resources Corporation, with a market cap of $335.78 million, operates through its subsidiaries to provide water, wastewater, and other services in Delaware, Maryland, and Pennsylvania.

Operations: Artesian Resources Corporation generates revenue primarily from its Regulated Utility segment, which accounts for $98.93 million, while also earning $6.97 million from non-utility services.

Dividend Yield: 3.7%

Artesian Resources offers a consistent dividend history with 129 consecutive quarterly payments, though its current yield of 3.73% falls short compared to top-tier US dividend payers. The company's dividends have grown steadily over the past decade, but they are not well covered by free cash flows despite a reasonable payout ratio of 60.1%. Recent executive changes include the interim appointment of Nicholle R. Taylor as CEO during Dian C. Taylor's leave, which could impact future strategic decisions.

  • Unlock comprehensive insights into our analysis of Artesian Resources stock in this dividend report.
  • Our valuation report unveils the possibility Artesian Resources' shares may be trading at a premium.
NasdaqGS:ARTN.A Dividend History as at Feb 2025

Haverty Furniture Companies

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Haverty Furniture Companies, Inc. is a specialty retailer of residential furniture and accessories in the United States with a market cap of $378.02 million.

Operations: Haverty Furniture Companies, Inc. generates revenue primarily through its home furnishings retailing segment, which accounted for $722.90 million.

Dividend Yield: 5.7%

Haverty Furniture Companies has announced a quarterly dividend of US$0.32 per share, yet its dividends have been volatile over the past decade. Despite trading at 40.1% below estimated fair value, the high payout ratio of 105.9% suggests earnings do not adequately cover dividends, though cash flows do provide coverage with a cash payout ratio of 78.3%. Recent financial results show declining sales and net income year-over-year, which may affect future dividend sustainability.

  • Click here and access our complete dividend analysis report to understand the dynamics of Haverty Furniture Companies.
  • Upon reviewing our latest valuation report, Haverty Furniture Companies' share price might be too pessimistic.
NYSE:HVT Dividend History as at Feb 2025

Merck

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Merck & Co., Inc. operates as a global healthcare company with a market cap of approximately $231.28 billion.

Operations: Merck & Co., Inc.'s revenue is primarily derived from its Pharmaceutical segment, which accounts for $57.40 billion, and its Animal Health segment, contributing $5.88 billion.

Dividend Yield: 3.6%

Merck's dividend, covered by both earnings (45.7% payout ratio) and cash flows (55.2% cash payout ratio), has been stable and growing over the past decade. Despite trading at 63% below estimated fair value, its dividend yield of 3.63% is lower than top-tier US payers. Recent developments include FDA priority review for KEYTRUDA in head and neck cancer treatment, European approval for WELIREG in RCC, and a class action lawsuit alleging misleading revenue projections impacting stock price stability.

  • Click to explore a detailed breakdown of our findings in Merck's dividend report.
  • In light of our recent valuation report, it seems possible that Merck is trading behind its estimated value.
NYSE:MRK Dividend History as at Feb 2025

Taking Advantage

  • Delve into our full catalog of 143 Top US Dividend Stocks here.
  • Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
  • Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Interested In Other Possibilities?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqGS:ARTN.A NYSE:HVT and NYSE:MRK.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10